CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $12.07 | $121K | 777,780 |
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −400 | $66.37 | $27K | 777,380 |
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,500 | $67.68 | $102K | 775,880 |
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,000 | $68.74 | $137K | 773,880 |
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,100 | $69.69 | $425K | 767,780 |
| 2026-06-03 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $12.07 | $121K | 1,923 |
| 2026-06-02 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-06-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −16,600 | $66.31 | $1.1M | 771,180 |
| 2026-06-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,400 | $66.75 | $227K | 767,780 |
| 2026-06-02 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 11,923 |
| 2026-06-01 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-06-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,610 | $66.39 | $107K | 786,170 |
| 2026-06-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −12,989 | $67.41 | $876K | 773,181 |
| 2026-06-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −5,401 | $68.35 | $369K | 767,780 |
| 2026-06-01 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 31,923 |
| 2026-06-01 | Connaughton Bernadette Director | Sale 10b5-1 | −1,625 | $66.21 | $108K | 43,669 |
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $12.07 | $121K | 777,780 |
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,100 | $68.10 | $143K | 775,680 |
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,350 | $68.88 | $231K | 772,330 |
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,950 | $69.79 | $276K | 768,380 |
Page 5 of 26 · 513 trades